VANDA Pharmaceuticals - Investor Relations - IR Home

Investor Relations

SEC Filings

SEC Filings

Filing date Form Description Filing Group View
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
424B4

Form of prospectus disclosing information facts events covered in both forms 424B1 424B3

Registration Statements
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
S-1MEF

Registration of up to an additional 20% of securities for any offering registered on an S-1

Registration Statements
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
EFFECT

EFFECT

Other
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML

Data provided by Kaleidoscope.

Copyright © 2005-2024 Vanda Pharmaceuticals Inc. |